Current Report Filing (8-k)
October 29 2019 - 4:59PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
October 23, 2019
AVALON GLOBOCARE CORP.
(Exact name of registrant as specified in its
charter)
Delaware
|
|
000-55709
|
|
47-1685128
|
(State or Other Jurisdiction of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification Number)
|
4400 Route 9 South, Suite 3100, Freehold, New
Jersey 07728
(Address of principal executive offices) (zip
code)
646-762-4517
(Registrant's telephone number, including area
code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
☐ Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
☒
Emerging growth company
If an
emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
|
Trading Symbols
|
|
Name of each exchange on which registered
|
Common Stock, $0.0001 par value per share
|
|
AVCO
|
|
The Nasdaq Capital Market
|
Item 2.03. Creation of a Direct
Financing Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
As previously disclosed, Avalon GloboCare Corp.
(the “Company”) entered into a Line of Credit Agreement (the “Line of Credit Agreement”) providing
the Company with a $20 million line of credit (the “Line of Credit”) from Wenzhao “Daniel” Lu (the “Lender”),
a significant shareholder and director of the Company. Under the Line of Credit, the Company received a loan from the Lender of
$500,000 on October 23, 2019 and $300,000 on October 24, 2019. Loans drawn under the Line of Credit bear interest at an annual
rate of 5% and each individual loan will be payable three years from the date of issuance. The Company may, at its option, prepay
any borrowings under the Line of Credit, in whole or in part at any time prior to maturity, without premium or penalty.
Item 9.01
Financial Statements and Exhibits
|
(1)
|
Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on September 3,
2019
|
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
AVALON GLOBOCARE CORP.
|
|
|
Date: October 28, 2019
|
By:
|
/s/ Luisa Ingargiola
|
|
Name:
|
Luisa Ingargiola
|
|
Title:
|
Chief Financial Officer
|
Avalon GloboCare (NASDAQ:AVCO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Avalon GloboCare (NASDAQ:AVCO)
Historical Stock Chart
From Apr 2023 to Apr 2024